Setmelanotide Completed Phase 2 Trials for BMI >27 kg/m2 Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01749137Phase 2 Study to Evaluate Safety and Efficacy of Rm-493 in Obese Patients